EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding Conditions for Newborn Screening—Findings from an Untargeted Metabolomics and Lipidomics Discovery Study

Alex J Ashenden iD, Tomas Rozek, Lucy Anastasi, Ayesha Chowdhury, Khoa Lam iD, Carol Wai-Kwan Siu iD, Jovanka King iD, Tracy Merlin, Nicholas Smith, Benjamin Saxon iD, Drago Bratkovic iD, Christopher Barnett und 4 weitere

International Journal of Neonatal Screening · 24.09.2026 · 12 (4) · 77

DOI: 10.3390/ijns12040077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 24.09.2026. Verfasst von Alex J Ashenden und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA 5000, Australia. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in metabolomics and genomics present new opportunities to expand newborn screening. Traditional screening approaches have relied on condition-specific biomarkers; however, untargeted metabolomic profiling may enable broader detection of genetic conditions. In this study, we developed and evaluated a novel metabolomic screening approach based on defining a reference profile representing a healthy newborn population. Retrospective dried blood spot samples from 2948 newborns were analysed using untargeted metabolomics and lipidomics, generating more than 30,000 features. A discovery cohort of over 2000 healthy newborns and newborns with genetic conditions was used to identify 1115 features that best discriminated between groups. These features formed the basis of a screening algorithm, which was subsequently evaluated in an independent validation cohort containing genetic conditions not represented in the discovery cohort. Across the discovery and validation cohorts, 180 cases representing 113 unique genetic conditions were assessed, including metabolic, haematological, neurological, and syndromic conditions. In the independent validation cohort, the algorithm achieved an area under the receiver operating characteristic curve of 0.799, with a specificity of over 99%. These findings demonstrate the potential of untargeted metabolomic profiling to identify newborns at increased risk of genetic disease and support future exploration in a multi-omic newborn screening design.

Schlagwörter

Stichwörter der Autor:innen

early detectiongenomic newborn screeninglipidomicsmetabolomicsmulti-omic NBSnewborn screening

Autor:innen und Institutionen

  • Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA 5000, Australia.
  • South Australia Neonatal Screening Centre, SA Pathology at Women's & Children's Hospital, Adelaide, SA 5006, Australia.
  • School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia.
  • Allergy & Clinical Immunology Department, Women's and Children's Hospital Network, Adelaide, SA 5006, Australia.
  • Immunology Directorate, SA Pathology, Adelaide, SA 5000, Australia.
  • Adelaide Health Technology Assessment (AHTA), School of Public Health, The University of Adelaide, Adelaide, SA 5000, Australia.

ORCID-Profile: Alex J Ashenden, Khoa Lam, Carol Wai-Kwan Siu, Jovanka King, Benjamin Saxon, Drago Bratkovic, Hamish S Scott, Enzo Ranieri, Karin S Kassahn

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Ashenden, A. J., Rozek, T., Anastasi, L., Chowdhury, A., Lam, K., Siu, C. W., King, J., Merlin, T., Smith, N., Saxon, B., Bratkovic, D., Barnett, C., Scott, H. S., Ranieri, E., Louise, J., & Kassahn, K. S. (2026). Expanding Conditions for Newborn Screening—Findings from an Untargeted Metabolomics and Lipidomics Discovery Study. International Journal of Neonatal Screening, 12(4), 77. https://doi.org/10.3390/ijns12040077

Vancouver

Ashenden AJ, Rozek T, Anastasi L, Chowdhury A, Lam K, Siu CW, et al. Expanding Conditions for Newborn Screening—Findings from an Untargeted Metabolomics and Lipidomics Discovery Study. International Journal of Neonatal Screening. 2026;12(4):77. doi:10.3390/ijns12040077

BibTeX
@article{Ashenden2026,
  author = {Ashenden, Alex J and Rozek, Tomas and Anastasi, Lucy and Chowdhury, Ayesha and Lam, Khoa and Siu, Carol Wai-Kwan and King, Jovanka and Merlin, Tracy and Smith, Nicholas and Saxon, Benjamin and Bratkovic, Drago and Barnett, Christopher and Scott, Hamish S and Ranieri, Enzo and Louise, Jennie and Kassahn, Karin S},
  title = {Expanding Conditions for Newborn Screening—Findings from an Untargeted Metabolomics and Lipidomics Discovery Study},
  journal = {International Journal of Neonatal Screening},
  year = {2026},
  volume = {12},
  number = {4},
  pages = {77},
  doi = {10.3390/ijns12040077}
}
Kostenlos starten →